Yulia Frenkel, Ph.D.
|2009||Graduate School - New Brunswick||Rutgers University, New Brunswick, New Brunswick, NJ, United States|
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Bauman JD, Patel D, Dharia C, et al. (2013) Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening. Journal of Medicinal Chemistry. 56: 2738-46|
|Tu X, Das K, Han Q, et al. (2010) Structural basis of HIV-1 resistance to AZT by excision. Nature Structural & Molecular Biology. 17: 1202-9|
|Frenkel YV, Gallicchio E, Das K, et al. (2009) Molecular dynamics study of non-nucleoside reverse transcriptase inhibitor 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (TMC278/rilpivirine) aggregates: correlation between amphiphilic properties of the drug and oral bioavailability. Journal of Medicinal Chemistry. 52: 5896-905|
|Das K, Bauman JD, Clark AD, et al. (2008) High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations. Proceedings of the National Academy of Sciences of the United States of America. 105: 1466-71|
|Frenkel YV, Clark AD, Das K, et al. (2005) Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. Journal of Medicinal Chemistry. 48: 1974-83|
|Janssen PA, Lewi PJ, Arnold E, et al. (2005) In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). Journal of Medicinal Chemistry. 48: 1901-9|